Bromfenac Acyl-β-D-Glucuronide
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Bromfenac Acyl-β-D-Glucuronide

● Failure Report Available

Catalogue No.:VE007439
CAS No.:N/A
Mol. Formula:C21H20BrNO9
Mol. Weight:510.29 g/mol

Additional information on Bromfenac Acyl-β-D-Glucuronide

Parent drug

Bromfenac

IUPAC Name

2-Amino-3-(4-bromobenzoyl)benzeneacetyl β-D-glucopyranosiduronic acid

Pharmacopeial Synonyms

N/A

Other Synonyms

N/A

Smiles

O[C@@H]1C(C(O)=O)O[C@@H](OC(CC2=CC=CC(C(C3=CC=C(Br)C=C3)=O)=C2N)=O)[C@@H](O)[C@H]1O

InChI

InChI=1S/C21H20BrNO9/c22-11-6-4-9(5-7-11)15(25)12-3-1-2-10(14(12)23)8-13(24)31-21-18(28)16(26)17(27)19(32-21)20(29)30/h1-7,16-19,21,26-28H,8,23H2,(H,29,30)/t16-,17-,18-,19?,21+/m0/s1

Description

The Bromfenac Acyl-β-D-Glucuronide standard is a well-characterized compound that aligns with key regulatory guidelines including USP, EMA, JP, and BP. It plays a crucial role in analytical method development method validation (AMV) and quality control (QC) processes particularly in the manufacturing of Bromfenac. This impurity standard is valuable for both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) ensuring reliable and precise analytical outcomes.

Bromfenac Acyl-β-D-Glucuronide: Synthesis Attempts and Failure Report (NAP Test)

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url